Aimei Health Technology II, the second blank check company formed by two China-based investors targeting small-cap health tech, raised the proposed deal size for its upcoming IPO on Monday.
The New York, NY-based company now plans to raise $100 million by offering 10 million units at $10. The company had previously filed to offer 6 million units at $10. Each unit consists of one share of common stock and one right to receive three-fourths of one ordinary share upon the consummation of an initial business combination. At the revised deal size, Aimei Health Technology II will raise 67% more in proceeds than previously anticipated.
The SPAC is led by CEO, CFO, and Director Heung Ming Wong, who also serves as CFO of Aimei Health Technology (AFJK), a SPAC that raised $60 million in December 2023, and had a pending merger agreement with China-based hydrogen producer United Hydrogen Global before terminating plans in July 2026.
Aimei Health Technology II was founded in 2024. It plans to list on the NYSE under the symbol AHJKU. D. Boral Capital is the sole bookrunner on the deal, replacing A.G.P.
